We reported the efficacy of CAP in selectively arresting the growth of HCC cells via triggering autophagy and proposed the EGFR/p-JNK/BIRC6/LC3B molecule axis that drove this process. Here, MAP1LC3B is linked to hepatocellular carcinoma.